CEACAM5 and periampullary adenocarcinoma: This combined biomarker panel significantly distinguished PC from normal controls and periampullary adenocarcinoma, with AUC values of 0.947 (Figure 6B, Table 3) and 0.858 (Figure 6C, Table 3), respectively, outperforming CA199 and CEA when used individually.